Role of computed tomography and [18F] fluorodeoxyglucose positron emission tomography image fusion in conformal radiotherapy of non-small cell lung cancer: a comparison with standard techniques with and without elective nodal irradiation
- PMID: 17455878
- DOI: 10.1177/030089160709300116
Role of computed tomography and [18F] fluorodeoxyglucose positron emission tomography image fusion in conformal radiotherapy of non-small cell lung cancer: a comparison with standard techniques with and without elective nodal irradiation
Abstract
Aims and background: Mediastinal elective node irradiation (ENI) in patients with non-small cell lung cancer candidate to radical radiotherapy is controversial. In this study, the impact of co-registered [18F]fluorodeoxyglucose-positron emission tomography (PET) and standard computed tomography (CT) on definition of target volumes and toxicity parameters was evaluated, by comparison with standard CT-based simulation with and without ENI.
Methods: CT-based gross tumor volume (GTVCT) was first contoured by a single observer without knowledge of PET results. Subsequently, the integrated GTV based on PET/CT coregistered images (GTVPET/CT) was defined. Each patient was planned according to three different treatment techniques: 1) radiotherapy with ENI using the CT data set alone (ENI plan); 2) radiotherapy without ENI using the CT data set alone (no ENI plan); 3) radiotherapy without ENI using PET/CT fusion data set (PET plan). Rival plans were compared for each patient with respect to dose to the normal tissues (spinal cord, healthy lungs, heart and esophagus).
Results: The addition of PET-modified TNM staging in 10/21 enrolled patients (48%); 3/21 were shifted to palliative treatment due to detection of metastatic disease or large tumor not amenable to high-dose radiotherapy. In 7/18 (39%) patients treated with radical radiotherapy, a significant (> or =25%) change in volume between GTVCT and GTVPET/CT was observed. For all the organs at risk, ENI plans had dose values significantly greater than no-ENI and PET plans. Comparing no ENI and PET plans, no statistically significant difference was observed, except for maximum point dose to the spinal cord Dmax, which was significantly lower in PET plans. Notably, even in patients in whom PET/CT planning resulted in an increased GTV, toxicity parameters were fairly acceptable, and always more favorable than with ENI plans.
Conclusions: Our study suggests that [18F]-fluorodeoxyglucose-PET should be integrated in no-ENI techniques, as it improves target volume delineation without a major increase in predicted toxicity.
Similar articles
-
Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1008-14. doi: 10.1016/j.ijrobp.2010.04.018. Epub 2010 Jul 23. Int J Radiat Oncol Biol Phys. 2011. PMID: 20656419
-
Analysis of incidental radiation dose to uninvolved mediastinal/supraclavicular lymph nodes in patients with limited-stage small cell lung cancer treated without elective nodal irradiation.Med Dosim. 2011 Winter;36(4):440-7. doi: 10.1016/j.meddos.2010.11.002. Epub 2011 Mar 11. Med Dosim. 2011. PMID: 21397488
-
Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):875-90. doi: 10.1016/s0360-3016(03)00743-0. Int J Radiat Oncol Biol Phys. 2003. PMID: 14529795
-
Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):709-19. doi: 10.1016/j.ijrobp.2006.09.046. Epub 2006 Dec 29. Int J Radiat Oncol Biol Phys. 2007. PMID: 17197120 Review.
-
Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC).Lung Cancer. 2007 Aug;57(2):125-34. doi: 10.1016/j.lungcan.2007.03.020. Epub 2007 May 2. Lung Cancer. 2007. PMID: 17478008 Review.
Cited by
-
The impact of PET/CT scanning on the size of target volumes, radiation exposure of organs at risk, TCP and NTCP, in the radiotherapy planning of non-small cell lung cancer.Rep Pract Oncol Radiother. 2013 Oct 17;19(3):182-90. doi: 10.1016/j.rpor.2013.09.006. eCollection 2014 May. Rep Pract Oncol Radiother. 2013. PMID: 24944819 Free PMC article.
-
The utility of positron emission tomography in the treatment planning of image-guided radiotherapy for non-small cell lung cancer.Front Oncol. 2014 Oct 7;4:273. doi: 10.3389/fonc.2014.00273. eCollection 2014. Front Oncol. 2014. PMID: 25340040 Free PMC article. Review.
-
Utilization of PET-CT in target volume delineation for three-dimensional conformal radiotherapy in patients with non-small cell lung cancer and atelectasis.Multidiscip Respir Med. 2013 Mar 18;8(1):21. doi: 10.1186/2049-6958-8-21. Multidiscip Respir Med. 2013. PMID: 23506629 Free PMC article.
-
Use of Positron Emission Tomography/Computed Tomography in Radiation Treatment Planning for Lung Cancer.Mol Imaging Radionucl Ther. 2016 Jun 5;25(2):50-62. doi: 10.4274/mirt.19870. Mol Imaging Radionucl Ther. 2016. PMID: 27277321 Free PMC article.
-
FDG-PET/CT imaging for tumor staging and definition of tumor volumes in radiation treatment planning in non-small cell lung cancer.Oncol Lett. 2014 Apr;7(4):1015-1020. doi: 10.3892/ol.2014.1874. Epub 2014 Feb 12. Oncol Lett. 2014. PMID: 24944661 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical